Extended benefit from sequential administration of docetaxel after standard fluorouracil, epirubicin, and cyclophosphamide regimen for node-positive breast cancer: the 8-year follow-up results of the UNICANCER-PACS01 trial.
暂无分享,去创建一个
J. Machiels | F. Penault-Llorca | B. Asselain | M. Campone | T. Petit | J. Canon | G. Romieu | G. Jerusalem | Anne-Laure Martin | M. Spielmann | M. Beauduin | B. Audhuy | D. Serin | C. Lévy | H. Roché | C. Veyret | H. Orfeuvre | J. Eymard | B. Coudert | G. Piot